Clinical Trial Update: Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy [Phase 3]

View source ↗

Summary

Phase 3 trial update for once-nightly sodium oxybate in narcolepsy assessing excessive daytime sleepiness and cataplexy completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataplexy
• Excessive Daytime Sleepiness
• Narcolepsy

Drugs mentioned

• sodium oxybate (brand: Xyrem or generic formulation used in study as sodium oxybate) (sodium oxybate)

Snippet

Sponsor: Avadel | Conditions: Excessive Daytime Sleepiness, Cataplexy | Phase 3 | Status: COMPLETED | Results posted: 2022-03-22